Quinine Global Market Opportunities And Strategies To 2035
By Product (Quinine Sulphate, Quinine Hydrochloride, Quinine Gluconate, Quinine Bisulphate), By Administration (Oral Administration, Intramuscular Administration, Intravenous Administration, Other Administrations), By Application (Malaria Treatment, Nocturnal Leg Cramps, Other Applications), By Enduser (Hospitals, Clinics, Other Endusers), And By Region, Opportunities And Strategies – Global Forecast To 2035
Quinine Market Definition
Quinine is a natural compound extracted from the bark of the cinchona tree, traditionally used to treat malaria. It works by interfering with the growth and reproduction of the malaria parasite in red blood cells. The quinine market consists of sales by entities (organizations, sole traders and partnerships) of quinine that is used by healthcare providers, hospitals, clinics, and patients, particularly in regions where malaria is prevalent or where quinine-based therapies are prescribed for muscle cramps. It is typically used when patients require treatment for malaria infections caused by Plasmodium parasites, especially in cases where resistance to other antimalarial drugs is observed, and also for managing nocturnal leg cramps under controlled medical supervision.
Quinine Market Size
The global quinine market reached a value of nearly $2,466.7 million in 2025, having grown at a compound annual growth rate (CAGR) of 7.1% since 2020. The market is expected to grow from $2,466.7 million in 2025 to $3,389.1 million in 2030 at a rate of 6.6%. The market is then expected to grow at a CAGR of 5.4% from 2030 and reach $4,410.8 million in 2035. Growth in the historic period resulted from high global prevalence of malaria, public-private partnerships in malaria eradication programs, rising public health programs and government procurement of antimalarial drugs and rising demand for tonic water and bitter beverages. Factors that negatively affected growth in the historic period were shift toward artemisinin-based combination therapies (acts) reducing reliance and side effects and toxicity concerns. Going forward, increasing off-label use for nocturnal leg cramps treatment, efforts towards the support for cinchona cultivation and processing, increasing rural healthcare penetration in malaria-endemic regions and support from global health organizations (WHO malaria programs) will drive the growth. Factors that could hinder the growth of the quinine market in the future include stringent regulatory restrictions, reduced physician preference due to side-effect profile and availability of synthetic bittering alternatives in beverages.
Quinine Market Segmentation
The quinine market is segmented by product, by administration, by application and by end-user.By Product –
The quinine market is segmented by product into:
- a) Quinine Sulphate
- b) Quinine Hydrochloride
- c) Quinine Gluconate
- D) Quinine Bisulphate
By Administration –
The quinine market is segmented by administration into:
- a) Oral Administration
- b) Intramuscular Administration
- c) Intravenous Administration
- d) Other Administration
By Application–
The quinine market is segmented by application into:
- a) Malaria Treatment
- b) Nocturnal Leg Cramps
- c) Other Applications
By End-User–
The quinine market is segmented by end-user into:
- a) Hospitals
- b) Clinics
- c) Other End Users
By Geography - The quinine market is segmented by geography into:
- China
- India
- Japan
- Australia
- Indonesia
- South Korea
- USA
- Canada
- Brazil
- France
- Germany
- UK
- Italy
- Spain
- Russia
-
o Asia Pacific
o Africa